|
1.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2.
|
Vaupel P, Briest S and Hockel M: Hypoxia
in breast cancer: pathogenesis, characterization and
biological/therapeutic implications. Wien Med Wochenschr.
152:334–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Sooriakumaran P and Kaba R: Angiogenesis
and the tumour hypoxia response in prostate cancer: a review. Int J
Surg. 3:61–67. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Higgins LH, Withers HG, Garbens A, et al:
Hypoxia and the metabolic phenotype of prostate cancer cells.
Biochim Biophys Acta. 1787:1433–1443. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Jensen RL: Brain tumor hypoxia:
tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a
therapeutic target. J Neurooncol. 92:317–335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
O’Connell MP, Marchbank K, Webster MR, et
al: Hypoxia induces phenotypic plasticity and therapy resistance in
melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer
Discov. Oct 8–2013.(Epub ahead of print). View Article : Google Scholar : 2013.
|
|
7.
|
Zeng W, Yang D, Long T, et al: CD147
promotes melanoma progression through hypoxia-induced MMP2
activation. Curr Mol Med. Oct 3–2013.(Epub ahead of print).
|
|
8.
|
Lee GW, Go SI, Cho YJ, et al:
Hypoxia-inducible factor-1alpha and excision repair
cross-complementing 1 in patients with small cell lung cancer who
received front-line platinum-based chemotherapy: a retrospective
study. J Thorac Oncol. 7:528–534. 2012. View Article : Google Scholar
|
|
9.
|
Zhang L, Huang G, Li X, et al: Hypoxia
induces epithelial-mesenchymal transition via activation of SNAI1
by hypoxia-inducible factor -1alpha in hepatocellular carcinoma.
BMC Cancer. 13:1082013. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Liu Y, Zhang JB, Qin Y, et al: PROX1
promotes hepatocellular carcinoma metastasis by way of
up-regulating hypoxia-inducible factor 1alpha expression and
protein stability. Hepatology. 58:692–705. 2013. View Article : Google Scholar
|
|
11.
|
Selvendiran K, Bratasz A, Kuppusamy ML,
Tazi MF, Rivera BK and Kuppusamy P: Hypoxia induces chemoresistance
in ovarian cancer cells by activation of signal transducer and
activator of transcription 3. Int J Cancer. 125:2198–2204. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Liang D, Ma Y, Liu J, et al: The hypoxic
microenvironment upgrades stem-like properties of ovarian cancer
cells. BMC Cancer. 12:2012012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Chang LH, Chen CH, Huang DY, Pai HC, Pan
SL and Teng CM: Thrombin induces expression of twist and cell
motility via the hypoxia-inducible factor-1alpha translational
pathway in colorectal cancer cells. J Cell Physiol. 226:1060–1068.
2011. View Article : Google Scholar
|
|
14.
|
Semenza GL: Hypoxia and cancer. Cancer
Metastasis Rev. 26:223–224. 2007. View Article : Google Scholar
|
|
15.
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Kizaka-Kondoh S, Inoue M, Harada H and
Hiraoka M: Tumor hypoxia: a target for selective cancer therapy.
Cancer Sci. 94:1021–1028. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
18.
|
Hurwitz H, Fehrenbacher L, Novotny W, et
al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for
metastatic colorectal cancer. N Engl J Med. 350:2335–2342. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Uemura M, Yamamoto H, Takemasa I, et al:
Jumonji domain containing 1A is a novel prognostic marker for
colorectal cancer: in vivo identification from hypoxic tumor cells.
Clin Cancer Res. 16:4636–4646. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Uemura M, Yamamoto H, Takemasa I, et al:
Hypoxia-inducible adrenomedullin in colorectal cancer. Anticancer
Res. 31:507–514. 2011.PubMed/NCBI
|
|
21.
|
Yamamoto H, Tei M, Uemura M, et al:
Ephrin-A1 mRNA is associated with poor prognosis of colorectal
cancer. Int J Oncol. 42:549–555. 2012.
|
|
22.
|
Noda T, Yamamoto H, Takemasa I, et al:
PLOD2 induced under hypoxia is a novel prognostic factor for
hepatocellular carcinoma after curative resection. Liver Int.
32:110–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Aihara T, Fujiwara Y, Ooka M, Sakita I,
Tamaki Y and Monden M: Mammaglobin B as a novel marker for
detection of breast cancer micrometastases in axillary lymph nodes
by reverse transcription-polymerase chain reaction. Breast Cancer
Res Treat. 58:137–140. 1999. View Article : Google Scholar
|
|
24.
|
Okami J, Dohno K, Sakon M, et al: Genetic
detection for micro-metastasis in lymph node of biliary tract
carcinoma. Clin Cancer Res. 6:2326–2332. 2000.PubMed/NCBI
|
|
25.
|
Aihara T, Fujiwara Y, Miyake Y, et al:
Mammaglobin B gene as a novel marker for lymph node micrometastasis
in patients with abdominal cancers. Cancer Lett. 150:79–84. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ouellette RJ, Richard D and Maicas E:
RT-PCR for mamma-globin genes, MGB1 and MGB2, identifies breast
cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol.
121:637–643. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Tassi RA, Bignotti E, Falchetti M, et al:
Mammaglobin B expression in human endometrial cancer. Int J Gynecol
Cancer. 18:1090–1096. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Tassi RA, Calza S, Ravaggi A, et al:
Mammaglobin B is an independent prognostic marker in epithelial
ovarian cancer and its expression is associated with reduced risk
of disease recurrence. BMC Cancer. 9:2532009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Bellone S, Tassi R, Betti M, et al:
Mammaglobin B (SCGB2A1) is a novel tumour antigen highly
differentially expressed in all major histological types of ovarian
cancer: implications for ovarian cancer immunotherapy. Br J Cancer.
109:462–471. 2013. View Article : Google Scholar
|
|
30.
|
Mohrin M, Bourke E, Alexander D, et al:
Hematopoietic stem cell quiescence promotes error-prone DNA repair
and mutagenesis. Cell Stem Cell. 7:174–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Adikrisna R, Tanaka S, Muramatsu S, et al:
Identification of pancreatic cancer stem cells and selective
toxicity of chemotherapeutic agents. Gastroenterology. 143:234–245.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Miyake M, Takemasa I, Matoba R, et al:
Heterogeneity of colorectal cancers and extraction of discriminator
gene signatures for personalized prediction of prognosis. Int J
Oncol. 39:781–789. 2011.PubMed/NCBI
|
|
33.
|
Takeno A, Takemasa I, Doki Y, et al:
Integrative approach for differentially overexpressed genes in
gastric cancer by combining large-scale gene expression profiling
and network analysis. Br J Cancer. 99:1307–1315. 2008. View Article : Google Scholar
|
|
34.
|
Takaishi S, Okumura T, Tu S, et al:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Vermeulen L, De Sousa EMF, van der Heijden
M, et al: Wnt activity defines colon cancer stem cells and is
regulated by the microenvironment. Nat Cell Biol. 12:468–476. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: an emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Ni J, Kalff-Suske M, Gentz R, Schageman J,
Beato M and Klug J: All human genes of the uteroglobin family are
localized on chromosome 11q12.2 and form a dense cluster. Ann NY
Acad Sci. 923:25–42. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Becker RM, Darrow C, Zimonjic DB, Popescu
NC, Watson MA and Fleming TP: Identification of mammaglobin B, a
novel member of the uteroglobin gene family. Genomics. 54:70–78.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Fiegl M, Haun M, Massoner A, et al:
Combination of cytology, fluorescence in situ hybridization for
aneuploidy, and reverse-transcriptase polymerase chain reaction for
human mammaglobin/mammaglobin B expression improves diagnosis of
malignant effusions. J Clin Oncol. 22:474–483. 2004. View Article : Google Scholar
|
|
40.
|
Brennan DJ, Jirstrom K, Kronblad A, et al:
CA IX is an independent prognostic marker in premenopausal breast
cancer patients with one to three positive lymph nodes and a
putative marker of radiation resistance. Clin Cancer Res.
12:6421–6431. 2006. View Article : Google Scholar
|
